By acting on both systems at once, tirzepatide can deliver stronger effects on appetite, fullness, and metabolic health than GLP-1 medications alone
Alonso-Gmez, Julia Wrnberg, Jess Vioque, Dora Romaguera, Jos Lpez-Miran European Journal of Nutrition .2026;[Epub] CrossRef Composite dietary antioxidant index and risk of metabolic dysfunction associated steatotic liver disease: evidence from a prospective cohort study Matin Sepehrinia, Sina Bazmi, Ali Nikparast, Elahe Etesami, Farhad Vahid, Gholamali Javdan, Hananeh Rozbahani, Jalaledin Mirzay Razaz, Mohammad Shafi Kuchay, Reza Homayounfar Nutrition & Metabolism .2026;[Epub] CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants Stefania Capuccio, Caterina Cocuzza, Grazia Letizia Di Marco, Alessandra Scamporrino, Salvatore Piro, Maurizio Russello Nutrients .2026
Enrollees eligible for the new program must be at least 18 years old and meet the following clinical criteria when GLP-1 treatment is started
shown to enhance mood.(43) Magnolia - bark herb supplies active honokiol, which is suggested to balance brain chemistry for relaxation without sedation.(44) MCT Oil supports the use of ketones for brain energy instead of carbohydrates
The achievement of weight-reduction targets was also more common with tirzepatide than semaglutide, further aligning with SURMOUNT-5 findings
doi: 10.1002/glia.22966 28 BoisvertM